A landmark agreement has been reached resolving lawsuit claims against Boston Scientific Corp’s transvaginal mesh product. According to Reuters, the company has agreed to pay $119 Million to settle over 2,970 injury claims by women, the first transvaginal mesh settlement for the company.
According to the report, the company faces as many as 25,000 mesh claims in U.S. and federal courts at this time.
(Resource: For Mesh Erosion Lawsuit Claims)
The settlement includes an important Texas judgement for $35 million, and does not constitute an admission of liability or guilt from the medical product company.
A safety alert was issued by the FDA in 2011 leading to investigations into the safety and possibility of health complications.
Mesh Product Complication Reports Include:
- Erosion (Exposure, Extrusion or Protrusion)
- Pain During Sexual Intercourse (dyspareunia)
- Abdominal Pain
- Organ Perforation
- Infections and Bleeding
- Urinary Problems
Health concerns were prompted following serious adverse event reports, leading to the FDA to issue an update declaring that, “serious complications associated with surgical mesh or transvaginal repair of POP are not rare.”
Boston Scientific is just one of a number of companies facing mesh product lawsuits across the nation over their products. The products were commonly implanted for treatment of pelvic organ prolapse, bladder incontinence, and other tissue rebuilding needs.
Even with the latest settlement having been announced and as many as 3,000 lawsuits being resolved, there are still thousands of pending mesh lawsuit claims.
“This large settlement is great news for claimants, the financial relief received will be impactful.”LawsuitLegal
Boston Scientific has long fought claims their mesh implants were defective and were responsible for the injury claims of women who had them implanted.
Initial trials were not decisive, with two mesh trials finding in favor of the defendants in Massachusetts, while two federal trials were lost in West Virgina and subsequently in Miami (Mesh Lawsuit Update).
Boston Scientific has been one of the last of the mesh manufacturers to agree to settle. Endo International reached a settlement agreement in a number of erosion claims for their mesh implants for $830 million. C.R. Bard settled out of court following a bellwether loss in court in 2013. AMS similarly faced losses in court and reached agreement, while Ethicon suffered a $11 million verdict loss for injuries in New Jersey.
Women who have had transvaginal mesh implanted within the last five years and have suffered complications they believe caused by the device, should speak with a transvaginal mesh attorney immediately to learn if they qualify to file a lawsuit for compensation.